These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29477396)

  • 41. Comparative effectiveness and health care spending--implications for reform.
    Weinstein MC; Skinner JA
    N Engl J Med; 2010 Feb; 362(5):460-5. PubMed ID: 20054039
    [No Abstract]   [Full Text] [Related]  

  • 42. Allocation of scarce resources.
    Steinberg A
    Assia Jew Med Ethics; 1995 May; 2(2):14-21. PubMed ID: 11653229
    [No Abstract]   [Full Text] [Related]  

  • 43. The cost of health care: what can a doctor do?
    Williams B
    Tenn Med; 2011; 104(10):21-5. PubMed ID: 22165466
    [No Abstract]   [Full Text] [Related]  

  • 44. Australia's 'fourth hurdle' drug review comparing costs and benefits holds lessons for the United States.
    Lopert R; Elshaug AG
    Health Aff (Millwood); 2013 Apr; 32(4):778-87. PubMed ID: 23569059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis.
    Warner KE
    Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470
    [No Abstract]   [Full Text] [Related]  

  • 46. Health economics: a beginner's guide.
    Thornton JG
    Br J Hosp Med; 1997 Dec; 58(11):547-50. PubMed ID: 10193467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health care in Australia: lessons from down under.
    Altman S; Jackson T
    Health Aff (Millwood); 1991; 10(3):129-46. PubMed ID: 1748372
    [No Abstract]   [Full Text] [Related]  

  • 48. Prescription for patient-centered care and cost containment.
    Daschle T; Domenici P; Frist W; Rivlin A
    N Engl J Med; 2013 Aug; 369(5):471-4. PubMed ID: 23803133
    [No Abstract]   [Full Text] [Related]  

  • 49. Painful reminders. New reports add emphasis to the cost and quality challenges in healthcare.
    May D
    Mod Healthc; 2011 Oct; 41(40):22. PubMed ID: 22049855
    [No Abstract]   [Full Text] [Related]  

  • 50. The humanizing of healthcare delivery. Tackling the high costs and closing the loopholes.
    Kerry J
    Healthc Leadersh Rep; 2004 Mar; 12(3):4-12. PubMed ID: 15106329
    [No Abstract]   [Full Text] [Related]  

  • 51. High-Cost Populations, The ACA, And More.
    Weil AR
    Health Aff (Millwood); 2016 Jan; 35(1):7. PubMed ID: 26733694
    [No Abstract]   [Full Text] [Related]  

  • 52. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving fairness in coverage decisions: insights from the Harvard Community Health Plan's LORAN Commission Report.
    Paris JJ
    Am J Bioeth; 2004; 4(3):103-4; discussion W40-2. PubMed ID: 16192160
    [No Abstract]   [Full Text] [Related]  

  • 54. Health care reform begins at home.
    Curran CR
    Nurs Econ; 1992; 10(4):248, 276. PubMed ID: 1508273
    [No Abstract]   [Full Text] [Related]  

  • 55. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR): Athens, Greece, 8-11 November 2008.
    Appl Health Econ Health Policy; 2008; 6(2-3):163-71. PubMed ID: 19231909
    [No Abstract]   [Full Text] [Related]  

  • 56. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.
    Malone DC; Ramsey SD; Patrick DL; Johnson FR; Mullins CD; Roberts MS; Willke RJ; Marshall DA
    Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Containing health-care costs: how Ford fights medical inflation.
    Shelton JK
    Manage Rev; 1978 Jul; 67(7):29-31. PubMed ID: 10308702
    [No Abstract]   [Full Text] [Related]  

  • 59. Good research practices for measuring drug costs in cost effectiveness analyses: an industry perspective: the ISPOR Drug Cost Task Force report--Part V.
    Mycka JM; Dellamano R; Kolassa EM; Wonder M; Ghosh S; Hay JW; Smeeding J
    Value Health; 2010; 13(1):25-7. PubMed ID: 19883402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical care in a changing economic environment.
    Luft HS
    Pharos Alpha Omega Alpha Honor Med Soc; 1985; 48(1):2-5. PubMed ID: 3919402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.